Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (281-290 of 554) with videos related to

Pageof 56
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2014
Proteopathic tau seeding predicts tauopathy in vivoBrandon B Holmes, Jennifer L Furman, Thomas E Mahan, et al.
JAMA Neurology|August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivityLiang Wang, Matthew R Brier, Abraham Z Snyder, et al.
The Lancet. Neurology|September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort studyStephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
Annals of Clinical and Translational Neurology|August 23, 2016
Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathyErik S Musiek, David D Xiong, Tirth Patel, et al.
Analytical Biochemistry|April 18, 2023
Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotypePaige E Lawler, James G Bollinger, Suzanne E Schindler, et al.
Molecular Neurodegeneration|April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjectsSaori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology|July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer diseaseAndrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2008
Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibitionByung Hee Han, Meng-Liang Zhou, Fadi Abousaleh, et al.
Molecular Neurodegeneration|March 16, 2023
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathyMonica Xiong, Chao Wang, Maud Gratuze, et al.
Annals of the New York Academy of Sciences|May 31, 2020
Alternatives to amyloid for Alzheimer's disease therapies-a symposium reportJennifer Cable, David M Holtzman, Bradley T Hyman, et al.
Pageof 56

Showing results (281-290 of 554) with videos related to

Sort By:
Pageof 56
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2014
Proteopathic tau seeding predicts tauopathy in vivoBrandon B Holmes, Jennifer L Furman, Thomas E Mahan, et al.
JAMA Neurology|August 21, 2013
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivityLiang Wang, Matthew R Brier, Abraham Z Snyder, et al.
The Lancet. Neurology|September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort studyStephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
Annals of Clinical and Translational Neurology|August 23, 2016
Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathyErik S Musiek, David D Xiong, Tirth Patel, et al.
Analytical Biochemistry|April 18, 2023
Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotypePaige E Lawler, James G Bollinger, Suzanne E Schindler, et al.
Molecular Neurodegeneration|April 27, 2012
Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjectsSaori Hata, Miyako Taniguchi, Yi Piao, et al.
Annals of Neurology|July 12, 2016
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer diseaseAndrei G Vlassenko, Lena McCue, Mateusz S Jasielec, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2008
Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibitionByung Hee Han, Meng-Liang Zhou, Fadi Abousaleh, et al.
Molecular Neurodegeneration|March 16, 2023
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathyMonica Xiong, Chao Wang, Maud Gratuze, et al.
Annals of the New York Academy of Sciences|May 31, 2020
Alternatives to amyloid for Alzheimer's disease therapies-a symposium reportJennifer Cable, David M Holtzman, Bradley T Hyman, et al.
Pageof 56